Global Paediatric Vaccine Market Research Report 2020

Publisher Name :
Date: 19-Feb-2020
No. of pages: 99
Inquire Before Buying

This report focuses on Paediatric Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Paediatric Vaccine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

- GlaxoSmithCline

- Merck

- Sanofi

- Bristol-Myers Squibb

- Abbott Laboratories

- Eli Lilly

- Pfizer

- F. Hoffmann-La Roche

- Novo Nordisk

Segment by Regions

- North America

- Europe

- China

- Japan

Segment by Type

- Pneumococcal

- Varicella

- Combinations

- Poliovirus

- Hepatitis

- MMR

- Pediatric Hormones

- HIB

- Allergy and Respiratory vaccines

- Other Pediatric vaccines

Segment by Application

- Age (0-3)

- Age (3-12)

- Age Above 12

Global Paediatric Vaccine Market Research Report 2020

Table of Contents
1 Paediatric Vaccine Market Overview
1.1 Product Overview and Scope of Paediatric Vaccine
1.2 Paediatric Vaccine Segment by Type
1.2.1 Global Paediatric Vaccine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Pneumococcal
1.2.3 Varicella
1.2.4 Combinations
1.2.5 Poliovirus
1.2.6 Hepatitis
1.2.7 MMR
1.2.8 Pediatric Hormones
1.2.9 HIB
1.2.10 Allergy and Respiratory vaccines
1.2.11 Other Pediatric vaccines
1.3 Paediatric Vaccine Segment by Application
1.3.1 Paediatric Vaccine Sales Comparison by Application: 2020 VS 2026
1.3.2 Age (0-3)
1.3.3 Age (3-12)
1.3.4 Age Above 12
1.4 Global Paediatric Vaccine Market Size Estimates and Forecasts
1.4.1 Global Paediatric Vaccine Revenue 2015-2026
1.4.2 Global Paediatric Vaccine Sales 2015-2026
1.4.3 Paediatric Vaccine Market Size by Region: 2020 Versus 2026
2 Global Paediatric Vaccine Market Competition by Manufacturers
2.1 Global Paediatric Vaccine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Paediatric Vaccine Revenue Share by Manufacturers (2015-2020)
2.3 Global Paediatric Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Paediatric Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Paediatric Vaccine Market Competitive Situation and Trends
2.5.1 Paediatric Vaccine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Paediatric Vaccine Players (Opinion Leaders)
3 Paediatric Vaccine Retrospective Market Scenario by Region
3.1 Global Paediatric Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Paediatric Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Paediatric Vaccine Market Facts & Figures by Country
3.3.1 North America Paediatric Vaccine Sales by Country
3.3.2 North America Paediatric Vaccine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Paediatric Vaccine Market Facts & Figures by Country
3.4.1 Europe Paediatric Vaccine Sales by Country
3.4.2 Europe Paediatric Vaccine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Paediatric Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Paediatric Vaccine Sales by Region
3.5.2 Asia Pacific Paediatric Vaccine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Paediatric Vaccine Market Facts & Figures by Country
3.6.1 Latin America Paediatric Vaccine Sales by Country
3.6.2 Latin America Paediatric Vaccine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Paediatric Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Paediatric Vaccine Sales by Country
3.7.2 Middle East and Africa Paediatric Vaccine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Paediatric Vaccine Historic Market Analysis by Type
4.1 Global Paediatric Vaccine Sales Market Share by Type (2015-2020)
4.2 Global Paediatric Vaccine Revenue Market Share by Type (2015-2020)
4.3 Global Paediatric Vaccine Price Market Share by Type (2015-2020)
4.4 Global Paediatric Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Paediatric Vaccine Historic Market Analysis by Application
5.1 Global Paediatric Vaccine Sales Market Share by Application (2015-2020)
5.2 Global Paediatric Vaccine Revenue Market Share by Application (2015-2020)
5.3 Global Paediatric Vaccine Price by Application (2015-2020)
6 Company Profiles and Key Figures in Paediatric Vaccine Business
6.1 GlaxoSmithCline
6.1.1 Corporation Information
6.1.2 GlaxoSmithCline Description, Business Overview and Total Revenue
6.1.3 GlaxoSmithCline Paediatric Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 GlaxoSmithCline Products Offered
6.1.5 GlaxoSmithCline Recent Development
6.2 Merck
6.2.1 Merck Paediatric Vaccine Production Sites and Area Served
6.2.2 Merck Description, Business Overview and Total Revenue
6.2.3 Merck Paediatric Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Merck Products Offered
6.2.5 Merck Recent Development
6.3 Sanofi
6.3.1 Sanofi Paediatric Vaccine Production Sites and Area Served
6.3.2 Sanofi Description, Business Overview and Total Revenue
6.3.3 Sanofi Paediatric Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Sanofi Products Offered
6.3.5 Sanofi Recent Development
6.4 Bristol-Myers Squibb
6.4.1 Bristol-Myers Squibb Paediatric Vaccine Production Sites and Area Served
6.4.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
6.4.3 Bristol-Myers Squibb Paediatric Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Bristol-Myers Squibb Products Offered
6.4.5 Bristol-Myers Squibb Recent Development
6.5 Abbott Laboratories
6.5.1 Abbott Laboratories Paediatric Vaccine Production Sites and Area Served
6.5.2 Abbott Laboratories Description, Business Overview and Total Revenue
6.5.3 Abbott Laboratories Paediatric Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Abbott Laboratories Products Offered
6.5.5 Abbott Laboratories Recent Development
6.6 Eli Lilly
6.6.1 Eli Lilly Paediatric Vaccine Production Sites and Area Served
6.6.2 Eli Lilly Description, Business Overview and Total Revenue
6.6.3 Eli Lilly Paediatric Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Eli Lilly Products Offered
6.6.5 Eli Lilly Recent Development
6.7 Pfizer
6.6.1 Pfizer Paediatric Vaccine Production Sites and Area Served
6.6.2 Pfizer Description, Business Overview and Total Revenue
6.6.3 Pfizer Paediatric Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Pfizer Products Offered
6.7.5 Pfizer Recent Development
6.8 F. Hoffmann-La Roche
6.8.1 F. Hoffmann-La Roche Paediatric Vaccine Production Sites and Area Served
6.8.2 F. Hoffmann-La Roche Description, Business Overview and Total Revenue
6.8.3 F. Hoffmann-La Roche Paediatric Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.8.4 F. Hoffmann-La Roche Products Offered
6.8.5 F. Hoffmann-La Roche Recent Development
6.9 Novo Nordisk
6.9.1 Novo Nordisk Paediatric Vaccine Production Sites and Area Served
6.9.2 Novo Nordisk Description, Business Overview and Total Revenue
6.9.3 Novo Nordisk Paediatric Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Novo Nordisk Products Offered
6.9.5 Novo Nordisk Recent Development
7 Paediatric Vaccine Manufacturing Cost Analysis
7.1 Paediatric Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Paediatric Vaccine
7.4 Paediatric Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Paediatric Vaccine Distributors List
8.3 Paediatric Vaccine Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Paediatric Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Paediatric Vaccine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Paediatric Vaccine by Type (2021-2026)
10.2 Paediatric Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Paediatric Vaccine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Paediatric Vaccine by Application (2021-2026)
10.3 Paediatric Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Paediatric Vaccine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Paediatric Vaccine by Region (2021-2026)
10.4 North America Paediatric Vaccine Estimates and Projections (2021-2026)
10.5 Europe Paediatric Vaccine Estimates and Projections (2021-2026)
10.6 Asia Pacific Paediatric Vaccine Estimates and Projections (2021-2026)
10.7 Latin America Paediatric Vaccine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Paediatric Vaccine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Paediatric Vaccine Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Paediatric Vaccine Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Paediatric Vaccine Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Paediatric Vaccine Manufacturers Covered in This Study
Table 5. Global Paediatric Vaccine Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Paediatric Vaccine Sales Share by Manufacturers (2015-2020)
Table 7. Global Paediatric Vaccine Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Paediatric Vaccine Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Paediatric Vaccine Average Price (USD/Units) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Paediatric Vaccine Sales Sites and Area Served
Table 11. Manufacturers Paediatric Vaccine Product Types
Table 12. Global Paediatric Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Paediatric Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paediatric Vaccine as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Paediatric Vaccine Players
Table 16. Global Paediatric Vaccine Sales (K Units) by Region (2015-2020)
Table 17. Global Paediatric Vaccine Sales Market Share by Region (2015-2020)
Table 18. Global Paediatric Vaccine Revenue (Million US$) by Region (2015-2020)
Table 19. Global Paediatric Vaccine Revenue Market Share by Region (2015-2020)
Table 20. North America Paediatric Vaccine Sales by Country (2015-2020) (K Units)
Table 21. North America Paediatric Vaccine Sales Market Share by Country (2015-2020)
Table 22. North America Paediatric Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Paediatric Vaccine Revenue Market Share by Country (2015-2020)
Table 24. Europe Paediatric Vaccine Sales by Country (2015-2020) (K Units)
Table 25. Europe Paediatric Vaccine Sales Market Share by Country (2015-2020)
Table 26. Europe Paediatric Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Paediatric Vaccine Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Paediatric Vaccine Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Paediatric Vaccine Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Paediatric Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Paediatric Vaccine Revenue Market Share by Region (2015-2020)
Table 32. Latin America Paediatric Vaccine Sales by Country (2015-2020) (K Units)
Table 33. Latin America Paediatric Vaccine Sales Market Share by Country (2015-2020)
Table 34. Latin America Paediatric Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Paediatric Vaccine Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Paediatric Vaccine Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Paediatric Vaccine Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Paediatric Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Paediatric Vaccine Revenue Market Share by Country (2015-2020)
Table 40. Global Paediatric Vaccine Sales (K Units) by Type (2015-2020)
Table 41. Global Paediatric Vaccine Sales Share by Type (2015-2020)
Table 42. Global Paediatric Vaccine Revenue (Million US$) by Type (2015-2020)
Table 43. Global Paediatric Vaccine Revenue Share by Type (2015-2020)
Table 44. Global Paediatric Vaccine Price (USD/Units) by Type (2015-2020)
Table 45. Global Paediatric Vaccine Sales (K Units) by Application (2015-2020)
Table 46. Global Paediatric Vaccine Sales Market Share by Application (2015-2020)
Table 47. Global Paediatric Vaccine Sales Growth Rate by Application (2015-2020)
Table 48. GlaxoSmithCline Paediatric Vaccine Corporation Information
Table 49. GlaxoSmithCline Description and Business Overview
Table 50. GlaxoSmithCline Paediatric Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 51. GlaxoSmithCline Main Product
Table 52. GlaxoSmithCline Recent Development
Table 53. Merck Paediatric Vaccine Corporation Information
Table 54. Merck Corporation Information
Table 55. Merck Paediatric Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 56. Merck Main Product
Table 57. Merck Recent Development
Table 58. Sanofi Paediatric Vaccine Corporation Information
Table 59. Sanofi Corporation Information
Table 60. Sanofi Paediatric Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 61. Sanofi Main Product
Table 62. Sanofi Recent Development
Table 63. Bristol-Myers Squibb Paediatric Vaccine Corporation Information
Table 64. Bristol-Myers Squibb Corporation Information
Table 65. Bristol-Myers Squibb Paediatric Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 66. Bristol-Myers Squibb Main Product
Table 67. Bristol-Myers Squibb Recent Development
Table 68. Abbott Laboratories Paediatric Vaccine Corporation Information
Table 69. Abbott Laboratories Corporation Information
Table 70. Abbott Laboratories Paediatric Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 71. Abbott Laboratories Main Product
Table 72. Abbott Laboratories Recent Development
Table 73. Eli Lilly Paediatric Vaccine Corporation Information
Table 74. Eli Lilly Corporation Information
Table 75. Eli Lilly Paediatric Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 76. Eli Lilly Main Product
Table 77. Eli Lilly Recent Development
Table 78. Pfizer Paediatric Vaccine Corporation Information
Table 79. Pfizer Corporation Information
Table 80. Pfizer Paediatric Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 81. Pfizer Main Product
Table 82. Pfizer Recent Development
Table 83. F. Hoffmann-La Roche Paediatric Vaccine Corporation Information
Table 84. F. Hoffmann-La Roche Corporation Information
Table 85. F. Hoffmann-La Roche Paediatric Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 86. F. Hoffmann-La Roche Main Product
Table 87. F. Hoffmann-La Roche Recent Development
Table 88. Novo Nordisk Paediatric Vaccine Corporation Information
Table 89. Novo Nordisk Corporation Information
Table 90. Novo Nordisk Paediatric Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2015-2020)
Table 91. Novo Nordisk Main Product
Table 92. Novo Nordisk Recent Development
Table 93. Sales Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Paediatric Vaccine Distributors List
Table 96. Paediatric Vaccine Customers List
Table 97. Market Key Trends
Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 99. Key Challenges
Table 100. Global Paediatric Vaccine Sales (K Units) Forecast by Type (2021-2026)
Table 101. Global Paediatric Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 102. Global Paediatric Vaccine Revenue (Million US$) Forecast by Type (2021-2026)
Table 103. Global Paediatric Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 104. Global Paediatric Vaccine Sales (K Units) Forecast by Application (2021-2026)
Table 105. Global Paediatric Vaccine Revenue (Million US$) Forecast by Application (2021-2026)
Table 106. Global Paediatric Vaccine Sales (K Units) Forecast by Region (2021-2026)
Table 107. Global Paediatric Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 108. Global Paediatric Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Global Paediatric Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Paediatric Vaccine
Figure 2. Global Paediatric Vaccine Sales Market Share by Type: 2020 VS 2026
Figure 3. Pneumococcal Product Picture
Figure 4. Varicella Product Picture
Figure 5. Combinations Product Picture
Figure 6. Poliovirus Product Picture
Figure 7. Hepatitis Product Picture
Figure 8. MMR Product Picture
Figure 9. Pediatric Hormones Product Picture
Figure 10. HIB Product Picture
Figure 11. Allergy and Respiratory vaccines Product Picture
Figure 12. Other Pediatric vaccines Product Picture
Figure 13. Global Paediatric Vaccine Consumption Market Share by Application: 2020 VS 2026
Figure 14. Age (0-3)
Figure 15. Age (3-12)
Figure 16. Age Above 12
Figure 17. Global Paediatric Vaccine Market Size 2015-2026 (US$ Million)
Figure 18. Global Paediatric Vaccine Sales Capacity (K Units) (2015-2026)
Figure 19. Global Paediatric Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Paediatric Vaccine Sales Share by Manufacturers in 2020
Figure 21. Global Paediatric Vaccine Revenue Share by Manufacturers in 2019
Figure 22. The Global 5 and 10 Largest Players: Market Share by Paediatric Vaccine Revenue in 2019
Figure 23. Paediatric Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Paediatric Vaccine Sales Market Share by Region (2015-2020)
Figure 25. Global Paediatric Vaccine Sales Market Share by Region in 2019
Figure 26. Global Paediatric Vaccine Revenue Market Share by Region (2015-2020)
Figure 27. Global Paediatric Vaccine Revenue Market Share by Region in 2019
Figure 28. North America Paediatric Vaccine Sales Market Share by Country in 2019
Figure 29. North America Paediatric Vaccine Revenue Market Share by Country in 2019
Figure 30. U.S. Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 31. U.S. Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. Canada Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 33. Canada Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Europe Paediatric Vaccine Sales Market Share by Country in 2019
Figure 35. Europe Paediatric Vaccine Revenue Market Share by Country in 2019
Figure 36. Germany Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 37. Germany Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. France Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 39. France Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. U.K. Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 41. U.K. Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Italy Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 43. Italy Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Russia Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 45. Russia Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Asia Pacific Paediatric Vaccine Sales Market Share by Region in 2019
Figure 47. Asia Pacific Paediatric Vaccine Revenue Market Share by Region in 2019
Figure 48. China Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 49. China Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Japan Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 51. Japan Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. South Korea Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 53. South Korea Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. India Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 55. India Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Australia Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 57. Australia Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Taiwan Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 59. Taiwan Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Indonesia Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 61. Indonesia Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Thailand Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 63. Thailand Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Malaysia Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 65. Malaysia Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Philippines Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 67. Philippines Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Vietnam Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 69. Vietnam Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Latin America Paediatric Vaccine Sales Market Share by Country in 2019
Figure 71. Latin America Paediatric Vaccine Revenue Market Share by Country in 2019
Figure 72. Mexico Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 73. Mexico Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Brazil Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 75. Brazil Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Argentina Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 77. Argentina Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Middle East and Africa Paediatric Vaccine Sales Market Share by Country in 2019
Figure 79. Middle East and Africa Paediatric Vaccine Revenue Market Share by Country in 2019
Figure 80. Turkey Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Saudi Arabia Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 83. Saudi Arabia Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. U.A.E Paediatric Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 85. U.A.E Paediatric Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Sales Market Share of Paediatric Vaccine by Type (2015-2020)
Figure 87. Sales Market Share of Paediatric Vaccine by Type in 2019
Figure 88. Revenue Share of Paediatric Vaccine by Type (2015-2020)
Figure 89. Revenue Market Share of Paediatric Vaccine by Type in 2019
Figure 90. Global Paediatric Vaccine Sales Growth by Type (2015-2020) (K Units)
Figure 91. Global Paediatric Vaccine Sales Market Share by Application (2015-2020)
Figure 92. Global Paediatric Vaccine Sales Market Share by Application in 2019
Figure 93. Global Revenue Share of Paediatric Vaccine by Application (2015-2020)
Figure 94. Global Revenue Share of Paediatric Vaccine by Application in 2020
Figure 95. GlaxoSmithCline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Price Trend of Key Raw Materials
Figure 105. Manufacturing Cost Structure of Paediatric Vaccine
Figure 106. Manufacturing Process Analysis of Paediatric Vaccine
Figure 107. Paediatric Vaccine Industrial Chain Analysis
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Porter's Five Forces Analysis
Figure 111. North America Paediatric Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. North America Paediatric Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Europe Paediatric Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 114. Europe Paediatric Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Latin America Paediatric Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 116. Latin America Paediatric Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Middle East and Africa Paediatric Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 118. Middle East and Africa Paediatric Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 119. Asia Pacific Paediatric Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 120. Asia Pacific Paediatric Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs